INSIGHTS ON PHARMACEUTICAL PACKAGING
-
5 Critical PUPSIT Considerations For Sponsors Targeting The EU Market
To ensure compliance with EU GMP Annex 1 guidelines and drug product approval, familiarize yourself with PUPSIT: how it works, why it’s needed, and strategies to maximize success.
-
Sterile Filling Readiness In The Drug Device Delivery Ecosystem
Explore how adaptable technologies and strategic partnerships help navigate Annex 1 compliance and technical hurdles to ensure the successful delivery of complex drug products.
-
Collaborate For Standardization In Large-Volume Subcutaneous Delivery
Establishing unified component standards through collaborative innovation eliminates unnecessary investment, reduces development timelines, and ensures scalable, patient-centered delivery systems.
-
Navigating Regulatory Expectations For Injectable Packaging
Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.
-
Why Shipping System Qualification Matters In Advanced Therapies12/2/2025
Ensuring the integrity of advanced therapies requires documented evidence of robust shipping processes. Qualification is essential for compliance and maintaining continuity across the supply chain.
-
Establishing And Safeguarding Shelf Life In Combination Products10/27/2025
Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.
-
Future Of Pharma Packaging: Trends, Tech, And Patient Solutions9/25/2025
Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.
-
How To Optimize Labeling In A Pharmaceutical Environment5/29/2025
Accurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.
-
Discover comprehensive clinical to commercial scale manufacturing services that deliver true life-cycle management for sterile drug products that bring treatments to patients with efficiency and quality.
-
Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.
-
Ropack Pharma Solutions welcomes the challenge of solving complex supply issues by using a unique blend of traditional and innovative services that can significantly shorten timelines, reduce cost and improve drug availability and patient compliance.
-
Ropack is pleased to provide a suite of primary contract packaging methods that meet the strictest standards for quality and safety.